1. Home
  2. Southern Africa
  3. Zambia
  • News

AIDS drug shortage creates concern

AIDS activists are concerned that Zambia's antiretroviral (ARV) treatment programme could be derailed by a lack of adequate planning. Health Minister Brian Chituwo recently announced in parliament that supplies of Triomune-30, a fixed-dose combination of Nevirapine, Lamivudine and Stavudine, had run out. Winston Zulu, coordinator of the AIDS NGO, Kara Trust, commented: "I am very scared about the provision of ARVs in Zambia because it is not being done well. As someone who has been taking ARVs for years, I know that bad treatment is worse than no treatment." But department of health spokesman Victor Mukonka told the UN news service PlusNews, there was "no reason to panic or get alarmed ... there will be no treatment interruptions - this is only one drug out of 16 formulations that are available in the country."

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join